TLDR Alphabet (GOOG) closed at $252.88 on September 22, 2025, with pre-market at $253.53. Stock hit $242.13 earlier this month, lifting its market cap to $2.92 trillion. DOJ ruling eased regulatory pressure, with analysts lifting price targets to $285. Google Cloud, ads, and AI remain major growth drivers, fueling revenue and margins. Shares delivered a [...] The post Alphabet Inc. ($GOOG) Stock: Hits Record Highs as Analysts Boost Targets appeared first on CoinCentral.TLDR Alphabet (GOOG) closed at $252.88 on September 22, 2025, with pre-market at $253.53. Stock hit $242.13 earlier this month, lifting its market cap to $2.92 trillion. DOJ ruling eased regulatory pressure, with analysts lifting price targets to $285. Google Cloud, ads, and AI remain major growth drivers, fueling revenue and margins. Shares delivered a [...] The post Alphabet Inc. ($GOOG) Stock: Hits Record Highs as Analysts Boost Targets appeared first on CoinCentral.

Alphabet Inc. ($GOOG) Stock: Hits Record Highs as Analysts Boost Targets

2025/09/23 22:11
3 min di lettura
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.

TLDR

  • Alphabet (GOOG) closed at $252.88 on September 22, 2025, with pre-market at $253.53.
  • Stock hit $242.13 earlier this month, lifting its market cap to $2.92 trillion.
  • DOJ ruling eased regulatory pressure, with analysts lifting price targets to $285.
  • Google Cloud, ads, and AI remain major growth drivers, fueling revenue and margins.
  • Shares delivered a 54% one-year return, far outpacing the S&P 500’s 17.38%.

Alphabet Inc. (NASDAQ: GOOG) closed at $252.88 on September 22, 2025, down 0.92% during the session, with pre-market trading at $253.53.

Alphabet Inc. (GOOG)

The stock recently reached an all-time high of $242.13 on September 11, lifting its market capitalization to $2.92 trillion. As of Sep 19th, a new all-time high was reached $256.70, and with the Sep 22nd day range of $250.81 to $256.31, edging a little closer to the all-time high. The momentum highlights Alphabet’s dominance across advertising, cloud, and AI markets.

Analyst Upgrades and DOJ Ruling

On September 22, Truist reaffirmed its “Buy” rating, raising the price target to $285 per share from $225. Piper Sandler also boosted its target to $285 from $220, maintaining an “Overweight” rating. Analysts cited the recent Department of Justice ruling, which requires Google to share data with competitors but avoids structural remedies that could disrupt its core business. This clarity helped ease market concerns about long-term regulatory risks.

AI and Search Market Strength

Alphabet continues to dominate search, holding over 90% market share despite the rise of generative AI platforms. Analysts noted AI-based searches account for only about 1% of referral traffic and minimal conversions, limiting their immediate impact on Google’s ad revenues. Instead, AI chatbots are expanding total search market opportunities. New ad products, including AI Max for Search Campaigns, are expected to drive growth in 2026.

Financial Performance and Valuation

Alphabet posted strong profitability with a 31.12% profit margin, 34.83% return on equity, and $115.57 billion in net income over the trailing twelve months. Its trailing P/E stands at 26.96, with a forward P/E of 23.98, signaling sustained earnings potential. The company maintains a solid balance sheet with $95.15 billion in cash and a conservative debt-to-equity ratio of 11.48%. Levered free cash flow reached nearly $50 billion.

Returns Outpacing the Market

Alphabet stock continues to outperform the broader market. Its one-year return of 54.27% nearly triples the S&P 500’s 17.38%. Over five years, Alphabet delivered a 247.48% return compared with the S&P 500’s 101.89%. The stock’s valuation reflects investor confidence in long-term AI-driven growth.

Conclusion

Alphabet’s record highs, supported by strong fundamentals, analyst upgrades, and regulatory clarity, reinforce its position as a top-tier growth stock. With robust AI integration and dominance in digital ads, Alphabet remains well-positioned to extend its market leadership.

The post Alphabet Inc. ($GOOG) Stock: Hits Record Highs as Analysts Boost Targets appeared first on CoinCentral.

Opportunità di mercato
Logo Capverse
Valore Capverse (CAP)
$0.09574
$0.09574$0.09574
-0.26%
USD
Grafico dei prezzi in tempo reale di Capverse (CAP)
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.

Potrebbe anche piacerti

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

TLDR Elliott Investment Management has built a multibillion-dollar stake in Synopsys (SNPS), per the WSJ. The activist firm wants Synopsys to generate more revenue
Condividi
Coincentral2026/03/23 17:00
Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

BitcoinWorld Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale Global energy markets face a sobering reality in 2025
Condividi
bitcoinworld2026/03/23 17:05
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Condividi
BitcoinEthereumNews2025/09/18 03:11